FDA clearance of the OneRF device for trigeminal neuralgia marks the company’s first expansion into the treatment of chronic pain. NeuroOne also sells its FDA-cleared OneRF sEEG brain ablation system ...

NeuroOne Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its OneRF ...

Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal ...

Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

Technologies has received U.S. Food and Drug Administration, FDA, clearance to market its OneRF Trigeminal Nerve Ablation ...

Marsha Garcia, founder of TN Warrior Racing, shares her journey of racing and advocacy for those suffering from chronic pain, ...

Ronald W. McClurg, CFO, said, "product revenue increased 105% to $1.7 million" and cited "sizable improvements year-over-year ...

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical ...

Trigeminal neuralgia (TN) is a prevalent chronic neuropathic pain (NP) considered to be among the most severe facial pains (Jones et al., 2019). It typically presents as sudden, shock-like, or intense ...

Transcutaneous vagus and trigeminal nerve stimulation for neuropsychiatric disorders: a systematic review Estimulação transcutânea do nervo vago e do nervo trigêmeo para o tratamento de distúrbios ...